Holen Sie sich die Stockscreener-App
231.22
0.69%
-1.605
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
Dohj LLC Acquires 1,335 Shares of AbbVie Inc. $ABBV - MarketBeat
Why AbbVie and Johnson & Johnson Could Outperform Pfizer - MarketBeat
WoodTrust Financial Corp Raises Stake in AbbVie Inc. $ABBV - MarketBeat
Winthrop Advisory Group LLC Has $845,000 Position in AbbVie Inc. $ABBV - MarketBeat
Citizens National Bank Trust Department Boosts Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV is Raub Brock Capital Management LP's 10th Largest Position - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Cut by Louisiana State Employees Retirement System - MarketBeat
Friedenthal Financial Acquires 1,261 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Cut by Kingswood Wealth Advisors LLC - MarketBeat
Why AbbVie Stock Soared in September - Nasdaq
AbbVie (NYSE:ABBV) Stock Price Up 1.4%What's Next? - MarketBeat
Spinal Cord Injury Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Kringle Pharma, Neuroplast, Abbvie, Mitsubishi Tanabe Pharma, Lineage Cell Therapeutics, NervGen - Barchart.com
KLP Kapitalforvaltning AS Buys 19,100 Shares of AbbVie Inc. $ABBV - MarketBeat
Hardy Reed LLC Sells 1,802 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Position Decreased by High Note Wealth LLC - MarketBeat
Shell Asset Management Co. Purchases 15,438 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie 2025: Moving on - PharmaLive
SteelPeak Wealth LLC Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
Presbyopia Market Analysis and Forecast Report 2025-2035 Featuring AbbVie, Eyenovia, Entod Pharma, L - PharmiWeb.com
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA for the Treatment of Upper Limb Essential Tremor - Investing News Network
AbbVie's (ABBV) Botox Study Shows Promising Results for Essentia - GuruFocus
AbbVie's Botox Shows Improvement In Movement Disorder Study - inkl
Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk - The Globe and Mail
AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week? - Yahoo Finance
AbbVie (ABBV) Achieves Positive Results in Phase 2 Trial for Essential Tremor - GuruFocus
AbbVie succeeds in mid-stage study of Botox for essential tremor - Seeking Alpha
AbbVie (ABBV) Positioned Amid Gilead's Patent Extension for Biktarvy - GuruFocus
AbbVie Says Botox Met Primary Endpoint in Phase 2 Upper Limb Essential Tremor Trial - MarketScreener
AbbVie reports positive results in essential tremor treatment trial By Investing.com - Investing.com Canada
AbbVie reports positive results in essential tremor treatment trial - Investing.com
AbbVie Says Phase 2 ELATE Trial Met Primary Endpoint For BOTOX To Treat Upper Limb Essential Tremor - Nasdaq
AbbVie announces positive phase 2 Elate trial results for onabotulinumtoxinA (Botox®) in treating upper limb essential tremor - MarketScreener
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential Tremor - Stock Titan
AbbVie expansion win for the city - Spectrum News
Prime Capital Investment Advisors LLC Sells 30,567 Shares of AbbVie Inc. $ABBV - MarketBeat
Comprehensive Financial Consultants Institutional Inc. Grows Stake in AbbVie Inc. $ABBV - MarketBeat
Belpointe Asset Management LLC Decreases Stock Position in AbbVie Inc. $ABBV - MarketBeat
Cullinan Associates Inc. Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Appleton Partners Inc. MA Purchases 2,010 Shares of AbbVie Inc. $ABBV - MarketBeat
Chung Wu Investment Group LLC Sells 2,360 Shares of AbbVie Inc. $ABBV - MarketBeat
Valeo Financial Advisors LLC Purchases 2,636 Shares of AbbVie Inc. $ABBV - MarketBeat
DAVENPORT & Co LLC Acquires 4,968 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Raised by Grimes & Company Inc. - MarketBeat
Merit Financial Group LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
Three Bridge Wealth Advisors LLC Makes New $495,000 Investment in AbbVie Inc. $ABBV - MarketBeat
Global Assets Advisory LLC Lowers Position in AbbVie Inc. $ABBV - MarketBeat
Can AbbVie Inc. stock outperform in 2025 bull marketQuarterly Performance Summary & Daily Volume Surge Signals - newser.com
Why AbbVie Inc. stock is in analyst buy zoneTrade Entry Summary & Technical Pattern Alert System - newser.com
AbbVie Inc. $ABBV Shares Acquired by Simplicity Wealth LLC - MarketBeat
Wealthcare Advisory Partners LLC Increases Holdings in AbbVie Inc. $ABBV - MarketBeat
Hill Island Financial LLC Invests $209,000 in AbbVie Inc. $ABBV - MarketBeat
Strid Group LLC Takes $2.05 Million Position in AbbVie Inc. $ABBV - MarketBeat
Talbot Financial LLC Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Checchi Capital Advisers LLC - MarketBeat
Clarius Group LLC Has $4.02 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Penobscot Investment Management Company Inc. - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Ascent Group LLC - MarketBeat
AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit - MSN
AbbVie Inc. $ABBV Shares Sold by AMF Tjanstepension AB - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Sava Infond d.o.o. - MarketBeat
Leerink Raises AbbVie (ABBV) Price Target on Strong Business Performance - MSN
Hudson Valley Investment Advisors Inc. ADV Purchases 2,704 Shares of AbbVie Inc. $ABBV - MarketBeat
111 Capital Increases Stake in AbbVie Inc. $ABBV - MarketBeat
QRG Capital Management Inc. Raises Stock Position in AbbVie Inc. $ABBV - MarketBeat
Grassi Investment Management Sells 1,225 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Precedent Wealth Partners LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Washington Growth Strategies LLC - MarketBeat
Franklin Street Advisors Inc. NC Boosts Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie updates 2025 earnings guidance to reflect $2.7 billion IPR&D expense - Investing.com
AbbVie trims annual profit forecast after expected $2.7 billion R&D hit - Reuters
AbbVie (ABBV) Projects Lower Q3 Earnings Due to IPR&D Costs - GuruFocus
AbbVie (ABBV) Anticipates Financial Impact from Third Quarter Ex - GuruFocus
ABBV Stock Outlook Revised for FY25 - GuruFocus
ABBV Surpasses Earnings Expectations with Strong Q3 Performance - GuruFocus
AbbVie expects $2.7 billion R&D charge in third quarter - The Mighty 790 KFGO
0.08%
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):